A Trial Of SU14813 In Patients With Advanced Solid Malignancies
NCT00982267
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
77
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Solid Tumors
Interventions
DRUG:
SU014813
Sponsor
Pfizer